Study Reveals Why HIV Mutation Resistant to Some Drugs Becomes Vulnerable to Islatravir
Researchers determined the crystal structure of an HIV reverse transcriptase mutation (F227C) and found it unexpectedly increases susceptibility to islatravir, a newly FDA-approved HIV drug. The mutation, which normally confers resistance to other antiretroviral drugs like doravirine, impairs the virus's ability to remove islatravir from its genetic material. This finding could inform the design of combination HIV treatments that strategically exploit such collateral sensitivities.
Scientists used X-ray crystallography to resolve the atomic structure of HIV-1 reverse transcriptase carrying the F227C mutation in complex with islatravir, revealing how this resistance mutation paradoxically increases the virus's vulnerability to the drug. The F227C mutation, which typically confers resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) including doravirine, causes conformational changes that impair the enzyme's ability to perform ATP-dependent removal of islatravir-terminated primers. Biochemical experiments confirmed that while the mutation does not significantly affect islatravir incorporation into viral DNA, it substantially reduces the virus's capacity to excise the drug, thereby enhancing susceptibility. The findings establish a direct structural and mechanistic link between resistance to one class of antivirals and hypersusceptibility to another, a phenomenon known as collateral sensitivity. This knowledge could enable clinicians to design rational combination regimens that exploit such vulnerabilities to overcome drug resistance.
What different sources said
- bioRxivCenter
Structural and Mechanistic Basis of F227C-Mediated Hypersusceptibility to Islatravir in HIV-1 Reverse Transcriptase
Related
Multiscale Brain Model Predicts Novel Propofol Anesthesia Biomarker Without Training on Clinical Data
Researchers developed a mechanistic computational model of thalamocortical brain circuits that successfully predicted a previously unnoticed dose-dependent biomarker of propofol anesthesia. The model, driven solely by GABA-A receptor modulation, reproduced empirical data from both macaques and humans without being fitted to any anesthesia-specific data. The findings suggest that simulation-first approaches could accelerate biomarker discovery in neuropharmacology without requiring large clinical datasets.
Green-Synthesized Zinc Oxide Nanoparticles from Mimosa pudica Show Biocompatibility with Bone Marrow Stem Cells in Lab Study
Researchers synthesized zinc oxide nanoparticles using Mimosa pudica leaf extract and tested their effects on human bone marrow mesenchymal stromal cells, finding the nanoparticles preserved cell viability, structure, and bone-forming capacity. The plant-derived nanoparticles outperformed both the raw plant extract and conventionally synthesized zinc oxide in maintaining cell metabolic activity over five days. The findings suggest these bioactive nanomaterials could be candidates for musculoskeletal tissue engineering, though the research remains at an early in vitro stage.
Study Compares Genetic Modeling Approaches for Dyadic Social Interactions in Animals
A new preprint study compared two statistical modeling approaches for analyzing the genetic basis of social interactions in animals, finding that dyadic models outperform marginal models that aggregate individual-level data. The research used pig aggression data from 797 finishing pigs across 59 social groups as a test case. The findings have implications for how animal geneticists model and interpret the heritable components of social behavior.